DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Israel grants $33 milion to GE, Medtronic, Change Healthcare to boost R&D Bringing high-quality jobs and biotech innovation to the country

ECRI to fill guidance void left by shutdown of NGC website Launching interim website with clinical practice guidelines this fall

Philips to oversee strategic revamping of German-based providers Upgrading and replacing equipment in two separate partnerships

Why Amazon’s winning the healthcare battle Analyzing the PillPack acquisition and other recent moves by the online retail giant

Bruker in deal to acquire JPK Instruments JPK makes microscopy instruments for biomolecular and cellular imaging

Medmo lets patients set price for radiology imaging tests A travel industry concept comes to healthcare

First radiology center opens in Zimbabwe capital to help curb shortage Currently 115 radiologists in country of 14 million people

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Veritas closes $1 billion GE Healthcare software unit buy Will run newly acquired business as a stand-alone company

Praxair in deal to sell European assets to Taiyo Nippon Sanso Move is dependent on the successful closing of the Praxair-Linde merger

FDA warns duodenoscope makers about failure to comply with requirements

por Thomas Dworetzky , Contributing Reporter
The U.S. Food and Drug Administration issued warning letters on Friday to all three duodenoscope manufacturers after the trio failed to comply with postmarket reprocessing surveillance studies.

The follow-ups were legally required of U.S. duodenoscope manufacturers Olympus, Fujifilm and Pentax in 2015, after inadequate reprocessing of the devices led to bacterial contamination causing illness and patient deaths.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



When the agency ordered the plans, the makers responded positively. A spokeswoman for Fujifilm said at that time that it "will continue to work with the agency to ensure the best long-term sustainable practices.”

A spokesman from Olympus stated that the issue was being taken "extremely seriously, and we intend to comply and provide the requested information." And a Pentax Medical representative said it "intends to cooperate fully with FDA to meet this request."

The approved study plans called for the manufacturers “to conduct a study to sample and culture reprocessed duodenoscopes that are in clinical use, to learn more about issues that contribute to contamination, as well as a human factors study to assess how well trained hospital staff are following the reprocessing instructions,” the agency noted it its recent letters.

So far, says the government, Olympus “has failed to commence data collection, and Pentax and Fujifilm have failed to provide sufficient data.”

Olympus and Pentax also failed to meet the requirements for human factors studies to see how well hospital staff are following reprocessing instructions. Fujifilm met those requirements.

“The FDA has taken important steps to improve the reprocessing of duodenoscopes, and we’ve seen a reduction in reports of patient infections, but we need the required postmarket studies to determine whether these measures are being properly implemented in real world clinical settings and whether we need to take additional action to further improve the safety of these devices,” Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health said in the statement, adding that, “we expect these device manufacturers to meet their study obligations to ensure patient safety.”

In 2013, the agency discovered that there was a link between multi-drug-resistant bacteria and duodenoscopes – despite the fact that users were following the manufacturer-recommended cleaning procedures.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS